Latest Cutting Edge Information Study Examines Pharmaceutical Pricing Trends, Strategies and Processes
RESEARCH TRIANGLE PARK, NC--(Marketwire - September 16, 2008) - Pharmaceutical business
intelligence firm Cutting Edge Information announces the launch of a new
report centered on pharmaceutical pricing. "Outcomes-Based Pharmaceutical
Pricing: Meeting Stakeholder Needs" examines trends, methodology and
processes in pharmaceutical pricing. It focuses on pricing teams'
challenges in satisfying various customer group demands and provides
recommendations and strategies for improvement.
A report brochure is available for download here:
According to the report, deciding the price on a drug used to be a task set
aside for later in the product development process. However, conflicting
demands from various customer groups and unpredictable market dynamics are
causing pharma pricing planning to be more strategic and integrated with
other commercialization tasks. Pricing activities, like other marketing
efforts, have been increasingly affected by globalization, and companies
have adapted their strategies accordingly.
"Significant changes have taken place in the pharmaceutical pricing
landscape since we conducted our previous pricing study a few years ago,"
said Haley Wynn, lead author of the report. "Pricing has gone from being
an overlooked activity to being a crucial tool in lifecycle management."
The 124-page report provides an in-depth analysis of pharmaceutical pricing
planning, processes, decision making and resources. Data are compiled from
surveys and interviews with leading executives at over 30 global life
sciences companies. Based on these findings and surveyed companies' best
practices, CEI analysts offer action points to guide companies to set the
right prices and optimize their profits.
The report contains 400+ metrics. Data focus on pricing teams' structures;
phase-by-phase pricing processes and methodology; and spending and staffing
resources. Metrics include the following:
-- Key internal stakeholders that influence pricing efforts
-- Resource support, innovative versus me-too drugs
-- Cross-functional involvement in pricing decisions
-- Share of companies with dedicated pricing departments
-- Lifecycle entry and exit points for functions involved in the pricing
-- Effectiveness ratings for pricing study types
-- 2008 pricing budgets and headcounts, by company size
-- 2008 headcounts broken down by geographic market and by company size
Contact Information: CONTACT INFORMATION:
For more information, contact:
For media inquiries, contact: